U.S. Physical Therapy, Inc.
HealthcareNYSE:USPH · New York Stock Exchange
-$0.23 today
Vol 0.12M · Avg 0.20M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
3.2%
avg 8.5%
ROIC
5.4%
avg 8.4%
ROA
1.3%
avg 4.0%
Analysis
ROIC is currently the strongest return metric at 5.4% versus its period average of 8.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Christopher J. Reading | Chief Executive Officer & Chairman | $2.51M | — | 62 | $139,088.00 | 0.91% |
Eric Joseph Williams | President & Chief Operating Officer | $1.53M | — | 60 | $40,331.00 | 0.27% |
Graham D. Reeve | Chief Operating Officer - West | $1.45M | — | 62 | $30,078.00 | 0.20% |
Carey Hendrickson | Chief Financial Officer | $1.11M | — | 64 | $27,808.00 | 0.18% |
Richard S. Binstein | Executive Vice President, General Counsel & Secretary | $961,736.00 | — | 65 | $24,867.00 | 0.16% |
Michael G. Mayrsohn | CEO of Metro & Director | $180,700.00 | — | 39 | $18,358.00 | 0.12% |
Jason Anderson | Vice President of Human Resources | — | — | — | $3,933.00 | 0.03% |
Jason T. Curtis | Interim CFO and Senior VP of Finance & Accounting | — | — | 50 | $3,933.00 | 0.03% |
Chadd Pence | Senior Vice President of Information Systems | — | — | — | — | — |
Matthew J. Condon | Senior Vice President of Strategic Initiatives & Partnerships | — | — | — | — | — |
Jayne Fleck Pool | Senior Vice President & Chief Compliance Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$324,776.88
Sells
11
$1.08M
Net Sentiment
$755,219.47
Net selling
Most Active
REEVE GRAHAM D.
6 transactions
1–10 of 14
Analysis
Insiders reported 3 buys worth $324,776.88 and 11 sells worth $1.08M over the last 12 months. That adds up to net selling of $755,219.47. REEVE GRAHAM D. was the most active insider with 6 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +5.4% | +5.6% (13yr)1 analysts |
| Revenue | N/A | N/A | +9.5% | +8.7% (13yr)1 analysts |
| Net Income | N/A | N/A | +7.5% | +7.2% (13yr)1 analysts |
| EBIT | N/A | N/A | +7.8% | +6.9% (13yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +9.5% over three years. Forward estimates point to Revenue at +8.7% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Select Medical Holdings Corporation
NYSE:SEM
$2.07B
Neogen Corporation
NASDAQ:NEOG
$1.98B
Astrana Health, Inc.
NASDAQ:ASTH
$1.91B
Healthcare Services Group, Inc.
NASDAQ:HCSG
$1.54B
AdaptHealth Corp.
NASDAQ:AHCO
$1.38B
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
$1.22B
The Pennant Group, Inc.
NASDAQ:PNTG
$1.14B
CONMED Corporation
NYSE:CNMD
$1.05B
GoodRx Holdings, Inc.
NASDAQ:GDRX
$918.57M
Zenas BioPharma, Inc.
NASDAQ:ZBIO
$883.93M
Who manages USPH?
U.S. Physical Therapy, Inc. (USPH) lists 11 active executives. The top listed executive is Carey Hendrickson, Chief Financial Officer.
Are USPH insiders buying or selling?
Recent insider activity shows net selling of $14.47M.
Explore More
Continue the stock analysis
Jump to another research area for this company.